Novocol Pharma

Novocol Pharma Contract Manufacturing & Development (CDMO) Profile

Novocol Pharma, located in Cambridge, Ontario, Canada, is focused on partnering its CMO services with pharmaceutical and device companies to utilize specialized sterile manufacturing capabilities in its FDA approved facility. Novocol offers full turnkey sterile cartridge, and RTU vials/pfs/cartridges (2025) manufacturing services including compounding, filling, inspection, device assembly and packaging. Novocol also offers full laboratory services for formulation and process development support, and full analytical & microbiology stability and testing services. Through our device division, Duoject Medical Systems, we also offer drug delivery design services specializing in injectable safety systems and lyo reconstitution.

CDMO Services:
Finished Dosage Forms (Small Molecule Drugs); Biologics; Medical Devices Cartridges; Pre-Filled Syringes (PFS); Sterile Vials Analytical Development; Drug Delivery System; Formulation Development; ICH Stability Testing; Process Development mRNA Vaccines; Protein Vaccines

Year Founded:

Head Office: Cambridge, Canada

Number of Facilities: 1-2

Facility locations: North America

Website: Visit the Novocol Pharma website

Linkedin: Connect on Linkedin

Current Capacity: New aseptic bulk cartridge filling line with 50 million annual capacity installed in 2024

New high-speed RTU filling line (vials/pfs) to be ready for market in 2025